The pharmacokinetics of metronidazole and gentamicin in a single preoperative dose as antibiotic prophylaxis in colorectal surgery;Farmacocinética del metronidazol y la gentamicina en dosis única preoperatoria para profilaxis antibiótica quirúrgica en cirugía colorrectal

Farmacia Hospitalaria

Volumn 32, Issue 2, 2008, Pages 77-82

  Ventura Cerda J M ^a   Alos Alminana M ^a   Nomdedeu Guinot, J ^a   Merino Sanjuan V ^b   Salvador Sanchis J L ^a  

^a HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Antibiotic prophylaxis; Colorectal surgery; Gentamicin; Metronidazol; Pharmacokinetics

Indexed keywords

GENTAMICIN; METRONIDAZOLE; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; BLOOD SAMPLING; CLINICAL ARTICLE; COLORECTAL SURGERY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFICACY; FEMALE; HUMAN; MALE; MICROBIOLOGICAL PARAMETERS; PHARMACOLOGICAL PARAMETERS; SINGLE DRUG DOSE; COLON DISEASE; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDY; RECTUM DISEASE;

ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; COLONIC DISEASES; FEMALE; GENTAMICINS; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RECTAL DISEASES;

EID: 58149374088     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-6343(08)72818-6     Document Type: Editorial

References (30)

1. Bratzler D.W., Houck P.M., Richards C., Steele L., Dellinger E.P., Fry D.E., et al. Use of antimicrobial prophylaxis for major surgery. Baseline results from the national surgical infection prevention project. Arch Surg 140 (2005) 174-182
2. Gul Y.A., Lian L.H., Jabar F.M., and Moissinac K. Antibiotic prophylaxis in elective colorectal surgery. ANZ J Surg 72 (2002) 275-278
3. American Society of Health-System Pharmacists. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Am J Health-Syst Pharm 56 (1999) 1839-1888
4. McDonald M., Grabsch E., Marshall C., and Forbes A. Single-versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust N Z J Surg 68 (1998) 388-396
5. Bucher P., Gervaz P., Soravia C., Mermillod B., Erne M., and Morel P. Randomized clinical trial of mechanical bowel preparation versus no preparation before elective left-side colorectal surgery. Br J Surg 92 (2005) 409-414
6. Song F., and Glenny A.M. Antimicrobial prophylaxis in colorectal surgery: a systematic review of randomized controlled trials. Br J Surg 85 (1998) 1232-1241
7. Alves A., Panis Y., Mathieu P., Mantion G., Kwiatkowsky F., Slim K., et al. Postoperative mortality and morbidity in French patients undergoing colorectal surgery. Arch Surg 140 (2005) 278-283
8. Fazio V.W., Tekkis P.P., Remzi F., and Lavery I.C. Assessment of operative risk in colorectal cancer surgery: the Cleveland Clinic Foundation colorectal cancer model. Dis Colon rectum 47 (2004) 2015-2024
9. Gladman M.A., Scott S.M., Lunniss P.J., and Williams N.S. Systematic review of surgical options for idiopathic megarectum and megacolon. Ann Surg 241 (2005) 562-574
10. Law W.l., and Chu K.W. Anterior resection for rectal cancer with mesorectal excision. A prospective evaluation of 622 patients. Ann Surg 240 (2004) 260-268
11. Reddy K.M., Meyer C.E.R., Palazzo F.F., Conaghan P., Blunt M.C., Stebbings W.S.L., et al. Postoperative stay following colorectal surgery: a study of factors associated with prolonged hospital stay. Ann R Coll Surg Engl 85 (2003) 111-114
12. Rau H.G., Mittelkötter U., Zimmermann A., Lachmann A., Köhler L., and Kullmann K.H. Perioperative infection prophylaxis and risk factor impact in colon surgery. Chemotherapy 46 (2000) 353-363
13. Lamp K.C., Freeman C.D., Klutman N.E., and Lacy M.K. Pharmacokinetics and pharmacodinamics of the nitroimidazole antimicrobials. Clin Pharmacokinet 36 (1999) 353-373
14. 2 generation. Clin microbial Infect 3 (1997) 82-88
15. Summary of antimicrobial susceptibility test results 2006 [consultado 13/7/2007]. Duke University Medical Center. Clinical Microbiology Laboratory. Durham, N. Carolina (Estados Unidos): 2006. Disponible en: http://pathology.mc.duke.edu/microbiology/susceptibility.htm
16. Credito K.L., Ednie L.M., Jacobs M.R., and Appelbaum P.C. Activity of telitromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology. Antimicrob Agents Chemother 43 (1999) 2027-2031
17. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing; fifteenth informational supplement. NCCLS document M100-S15. Wayne, Pensilvania (Estados Unidos): NCCLS; 2005.
18. Navarro F., Miró E., and Mirelis B. Lectura interpretada del antibiograma de enterobacterias. Enferm Infecc Microbiol Clin 20 (2002) 225-234
19. Weinbren M.J., Johnson A.P., and Woodford N. Defining high-level gentamicin resistance in enterococci. J Antimicrob Chemother 45 (2000) 404-405
20. Liddy H., and Holliman R. Group B Streptococcus highly resistant to gentamicin. J Antimicrob Chemother 50 (2002) 142-143
21. Markantonis S.L., Kostopanagiotou G., Panidis D., Smirniotis V., and Voros D. Effects of blood loss and fluid volume replacement on serum and tissue gentamicin concentrations during colorectal surgery. Clin Ther 26 (2004) 271-281
22. Soriano F. Aspectos farmacocinéticos y farmacodinámicos para la lectura interpretada del antibiograma. Enferm Infecc microbiol Clin 20 (2002) 407-412
23. Wood Wallace A., Jones M., and Bertino J.S. Evaluation of four once-daily aminoglycoside dosing nomograms. Pharmacotherapy 22 (2002) 1077-1083
24. Zelenitsky S.A., Ariano R.E., Harding G.K.M., and Silverman R.E. Antibiotic pharmacodinamics in surgical prophylaxis: an association between intraoperative antibiotic concentrations and efficacy. Antimicrob Agents Chemother 46 (2002) 3026-3030
25. Bartal C., Danon A., Schlaeffer F., Reisenberg K., Alkan M., Smoliakov R., et al. Pharmacokinetic dosing of aminoglycosides: a controlled trial. Am J Med 114 (2003) 194-198
26. Christensen S., Ladefoged K., and Frimodt-Mfller N. Experience with once daily dosing of gentamicin: considerations regarding dosing and monitoring. Chemotherapy 43 (1997) 442-450
27. Ventura Cerdá J.M., Nomdedeu Guinot J., Alós Almiñana M., Ángel Yepes V., Pérez Salinas I., and Salvador Sanchís J.L. Dosis única preoperatoria de metronidazol más gentamicina para profilaxis antibiótica en cirugía colorrectal. Med Clin (Barc) 129 (2007) 121-126
28. Matthews I., Kirkpatrick C., and Holdford N. Quantitative justification for target concentration intervention - parameter variability and predictive performance using population pharmacokinetic models for aminoglycosides. Br J Clin Pharmacol 58 (2004) 8-19
29. Duffull S.B., Kirkpatrick C.M.J., and Begg E.J. Comparison of two Bayesian approaches to dose-individualization for once-daily aminoglycoside regimens. Br J Clin Pharmacol 43 (1997) 125-135
30. Mouton J.W., and Vinks A.A. Pharmacokinetic/pharmacodynamic modellig antibacterials in vitro and in vivo using bacterial growth and kill kinetics. Clin Pharmacokinet 44 (2005) 201-210